The drugmaker is suspending its dividend and slashing staff. Antony Currie and Robert Cyran explain why that might not be enough to cure the ills caught from a debt-laden deal in 2015.
from Reuters Video: Breakingviews http://ift.tt/2jVc2f3
via
IFTTT
No comments:
Post a Comment